SCHEMBL27384644

SCHEMBL27384644

CC(C)c1ccc2cc(CNC(=O)N3CCCCC3)[nH]c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.46
▸ EIF4A3 P38919 1/20 0.45
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ RAB9A P51151 4/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ GAA P10253 1/20 0.40
▸ EPHX2 P34913 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384640 0.97 MAPK1 (0.46) MAPK1EIF4A3BCHEACHERAB9A
SCHEMBL27384257 0.83 RAB9A (0.50) MAPK1RAB9ANPC1GAAALDH1A1
SCHEMBL27384259 0.83 KMT2A (0.48) MAPK1RAB9ANPC1ALDH1A1MAPT
SCHEMBL27247001 0.81 MTNR1A (0.56) RAB9ANPC1ALDH1A1MEN1KMT2A
SCHEMBL27384340 0.80 EIF4A3 (0.47) MAPK1EIF4A3RAB9ANPC1EPHX2
SCHEMBL27384339 0.80 MAPK1 (0.42) MAPK1EIF4A3RAB9ANPC1EPHX2
SCHEMBL27384655 0.79 EIF4A3 (0.48) MAPK1EIF4A3RAB9ANPC1EPHX2
SCHEMBL27384854 0.79 MAPK1 (0.41) MAPK1RAB9ANPC1EPHX2ALDH1A1
SCHEMBL27382616 0.78 EIF4A3 (0.51) MAPK1EIF4A3RAB9AALDH1A1HPGD
SCHEMBL27383636 0.77 EIF4A3 (0.47) EIF4A3RAB9ANPC1SMN1; SMN2METTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback